|
Volumn 2, Issue 6, 2013, Pages
|
Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
BENZIMIDAZOLE DERIVATIVE;
BETA ALANINE;
DABIGATRAN;
DRUG DERIVATIVE;
AGE;
AGED;
ARTICLE;
ATTITUDE TO HEALTH;
BLEEDING;
BLOOD;
CEREBROVASCULAR ACCIDENT;
CHEMICALLY INDUCED DISORDER;
CHI SQUARE DISTRIBUTION;
CLINICAL PRACTICE;
COMORBIDITY;
DOSE CALCULATION;
DOSING;
DRUG SUBSTITUTION;
FEMALE;
HEART ATRIUM FIBRILLATION;
HUMAN;
MALE;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PATIENT EDUCATION;
PHARMACOEPIDEMIOLOGY;
PROPORTIONAL HAZARDS MODEL;
REGISTER;
RISK;
RISK FACTOR;
SOCIOECONOMICS;
STATISTICAL MODEL;
TIME;
TREATMENT OUTCOME;
UNITED STATES;
VERY ELDERLY;
ANTICOAGULANT;
ATRIAL FIBRILLATION;
DABIGATRAN;
DOSING;
PHARMACOEPIDEMIOLOGY;
ADMINISTRATION, ORAL;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
ANTICOAGULANTS;
ATRIAL FIBRILLATION;
BENZIMIDAZOLES;
BETA-ALANINE;
CHI-SQUARE DISTRIBUTION;
COMORBIDITY;
DRUG DOSAGE CALCULATIONS;
DRUG SUBSTITUTION;
FEMALE;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HEMORRHAGE;
HUMANS;
LOGISTIC MODELS;
MALE;
MIDDLE AGED;
ODDS RATIO;
PATIENT EDUCATION AS TOPIC;
PHYSICIAN'S PRACTICE PATTERNS;
PROPORTIONAL HAZARDS MODELS;
REGISTRIES;
RISK FACTORS;
SOCIOECONOMIC FACTORS;
STROKE;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 84901236672
PISSN: None
EISSN: 20479980
Source Type: Journal
DOI: 10.1161/JAHA.113.000535 Document Type: Article |
Times cited : (96)
|
References (0)
|